- Home
- CRMD vs JBGS Comparison
CRMD vs JBGS Comparison
Compare CRMD & JBGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRMD | JBGS |
|---|---|---|
| Founded | 2006 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 958.1M | 1.0B |
| IPO Year | 2010 | 2017 |
Fundamental Metrics
Financial Performance| Metric | CRMD | JBGS |
|---|---|---|
| Price | $7.77 | $16.77 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 7 | 1 |
| Target Price | $15.29 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 4.2M | 451.7K |
| Earning Date | 11-12-2025 | 02-17-2026 |
| Dividend Yield | N/A | ★ 4.16% |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.25 | N/A |
| Revenue | $214,303,672.00 | ★ $501,226,000.00 |
| Revenue This Year | $629.55 | N/A |
| Revenue Next Year | $8.34 | $1.79 |
| P/E Ratio | $3.45 | ★ N/A |
| Revenue Growth | ★ 1647.67 | N/A |
| 52 Week Low | $5.60 | $13.28 |
| 52 Week High | $17.43 | $24.30 |
Technical Indicators
Market Signals| Indicator | CRMD | JBGS |
|---|---|---|
| Relative Strength Index (RSI) | 38.67 | 41.92 |
| Support Level | $7.15 | $16.80 |
| Resistance Level | $7.59 | $17.82 |
| Average True Range (ATR) | 0.39 | 0.45 |
| MACD | 0.12 | -0.04 |
| Stochastic Oscillator | 75.94 | 25.69 |
Price Performance
Historical ComparisonAbout CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About JBGS JBG SMITH Properties
JBG SMITH Properties is a real estate investment trust based in the United States. It owns, operates, invests in, and develops real estate assets concentrated in amenity-rich, metro-served submarkets in and around Washington, DC. In addition, the company also provides fee-based real estate services to legacy funds through its third-party real estate services business. The operating segments of the company are commercial, multifamily, and third-party asset management and real estate services. It generates maximum revenue from the commercial segment.